Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Alza and Warner-Lambert sign distribution agreement for nasal decongestant OTC

Dec. 12, 1997

Periodontix and Child Health Corporation of America develop new CF Rx

Dec. 10, 1997

Alliance and Hoechst Marion Roussel terminate LiquiVent agreement

Dec. 10, 1997

FDA advisory committee recommends approval of TOBI

Dec. 9, 1997

Byk Gulden presents new PDE IV inhibitors

Dec. 8, 1997

Plant extract with both antiinflammatory and antihistaminic activity

Dec. 4, 1997

New glucocorticoid from Kissei under development for asthma

Dec. 4, 1997

Takeda's PAF antagonist evaluated in preclinical model of asthma

Dec. 2, 1997

Dual-action compound YM-158 shows potential for asthma

Dec. 1, 1997

Preclinical results reported for Novartis' PDE IV inhibitor

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...